# US 2023/0054253 A1 · Methods and systems for multi-omic interventions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0054253 A1
- Document ID: US20230054253A1
- Status: Published application
- Kind: A1
- Application number: 17/817,562
- Filed: 2022-08-04
- Published: 2023-02-23
- Earliest claimed: 2021-08-06
- Applicants: Food Rx and AI, Inc.
- Inventors: Ranjan Sinha; Shreyas V. Kumbhare; Inti Pedroso; Daniel E. Almonacid
- Web page: https://patentgrep.com/patent/US20230054253A1

## CPC

- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B 40/20: Supervised data analysis
- G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H 20/70: relating to mental therapies, e.g. psychological therapy or autogenous training
- G16H 50/30: for calculating health indices; for individual health risk assessment
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A platform providing methods and systems for prevention and/or treatment of a health condition, where a method can include: simultaneously reducing severity symptoms of the health condition and comorbid conditions upon: receiving a set of samples from one or more subjects; receiving a biometric dataset from one or more subjects; receiving a lifestyle dataset from one or more subjects; returning a genomic single nucleotide polymorphism (SNP) profile and a baseline microbiome state upon processing the set of samples, the biometric dataset, and the lifestyle dataset with a set of transformation operations; generating personalized intervention plans for the one or more subjects upon processing the genomic SNP profile and the baseline microbiome state with a multi-omic model; and executing the personalized intervention plans for the one or more subjects.

## Claims

### Claim 1

A method for prevention and treatment of a digestive condition, the method comprising:
simultaneously reducing severity of a set of digestive disorder and comorbid condition symptoms by at least 30% and producing greater than 2% weight loss in a subject upon:
receiving a sample from the subject;
receiving a biometric dataset from the subject;
receiving a lifestyle dataset from the subject;
returning a genomic profile and one or more microbiome states including a baseline profile of the subject upon processing the set of samples, the biometric dataset, and the lifestyle dataset with a set of transformation operations;
generating a personalized intervention plan for the subject upon processing the genomic profile and the one or more microbiome states with a multi-omic model; and
executing the personalized intervention plan for the subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the set of digestive disorder and comorbid condition symptoms comprises: chronic inflammatory pain symptoms, headache symptoms, migraine symptoms, brain fog and cognitive symptoms, depression symptoms, anxiety symptoms, pain symptoms, insomnia symptoms, sleep apnea symptoms, disturbed sleep symptoms, osteoarthritis symptoms, rheumatoid arthritis symptoms, persistent joint aches symptoms, joint swelling symptoms, skin condition symptoms, acne symptoms, eczema symptoms, psoriasis symptoms, rashes/dryness symptoms, itching symptoms, hair loss symptoms, hypothyroidism symptoms, polycystic ovary syndrome symptoms, and fatigue symptoms.

### Claim 3 (depends on 1)

The method of claim 1, further comprising simultaneously reducing hemoglobin A1c levels, fasting blood sugar, glycemic response, high density lipids, and low density lipids by at least 1% in the subject.

### Claim 4 (depends on 1)

The method of claim 1, wherein the set of digestive disorder condition symptoms are associated with a functional gastrointestinal disease (FGID).

### Claim 5 (depends on 1)

The method of claim 1, wherein the set of digestive disorder condition symptoms comprises symptoms associated with irritable bowel syndrome (IBS), constipation, bloating, gassiness, cramping, belly pain, diarrhea, and heartburn.

### Claim 6 (depends on 1)

The method of claim 1, wherein the set of samples comprises a saliva sample and at least one gut sample, and wherein the set of transformation operations comprises nucleic acid extraction, purification, and genotyping for the saliva sample, and amplification of and generating a set of sequencing reads from the gut sample.

### Claim 7 (depends on 6)

The method of claim 6, wherein the set of transformation operations further comprises demultiplexing, generating amplicon sequence variants (ASVs), and performing taxonomic and functional annotation of the set of sequencing reads based on at least one of local and global alignment methods, and graph based methods, linear and nonlinear dimensionality reduction, and applications of supervised, semi-supervised and unsupervised machine or statistical inference methods to derive informative features from the microbiome profiles.

### Claim 8 (depends on 6)

The method of claim 6, wherein the set of transformation operations further comprises imputing missing sites, determining genetic ancestry of the subject, estimating genetic parameters comprising genetic diversity and homozygosity, estimating scores representing inherited risk, and estimated values of qualitative, continuous and categorical traits which are normalized to biological gender, genetic ancestry, age, socioeconomic status, biometric measurements and life-style variables.

### Claim 9 (depends on 1)

The method of claim 1, wherein receiving the biometric dataset comprises receiving a Bristol stool scale, stool frequency and abdominal pain intensity values of the subject.

### Claim 10 (depends on 1)

The method of claim 1, wherein receiving the biometric dataset comprises receiving bodyweight, body mass index (BMI), blood chemical and biochemical information, and an inflammatory marker profile of the subject, and wherein the biometric dataset comprises: medication use, fasting blood sugar, glycemic response, high density lipids, low density lipids, fecal calprotectin, blood interleukins, c-reactive protein, and blood cell counts and compositions of the subject.

### Claim 11 (depends on 1)

The method of claim 1, wherein the lifestyle dataset comprises data derived from: sleep quality and quantity, exercise type and duration, stress and meditation, energy levels, dietary behavior, cravings, foods consumed, foods avoided, prescription and over the counter medications, social determinants of health, familial determinants of health, and work determinants of health, and state of symptoms of the subject.

### Claim 12 (depends on 1)

The method of claim 1, wherein the multi-omic model comprises a first subarchitecture for processing genomic input data associated with lactose intolerance, histamin intolerance, alcohol intolerance, gluten sensitivity, cockroach allergy, dust mites allergy, pets allergy, hay fever, pollen allergy, grass allergy, milk allergy and peanut allergies, caffeine metabolism, and inflammatory markers, said first subarchitecture structured to infer non-genotyped alleles by means of at least one of dimensionality reduction and statistical inferences methods for data imputations, with detection and encoding values of a set of risk alleles of the genomic profile for the subject.

### Claim 13 (depends on 12)

The method of claim 12, wherein the set of risk alleles comprises: rs2472297 (risk allele C) and rs762551 (risk allele C) associated with gene CYP1A2, rs2187668 (risk allele T) associated with gene HLA-DQ 2.5, rs2395182 (risk allele T) associated with gene HLA-DQ 2.2 (M1), rs4639334 (risk allele A) associated with gene HLA-DQ7, rs4713586 (risk allele G) associated with gene HLA-DQ 2.2 (M3), rs7454108 (risk allele C) associated with gene HLA-DQ8 and rs7775228 (risk allele C) associated with gene HLA-DQ 2.2, rs182549 (risk allele C) associated with gene MCM6 and rs4988235 (risk allele G) associated with gene MCM6, rs324015 (risk allele T) associated with gene STAT6, rs7192 (risk allele T) associated with gene HLA-DRA, rs9275596 (risk allele C) associated with gene MTCO3P1-AL662789.1, rs1800629 (risk allele A) associated with gene TNF, rs1800896 (risk allele T) associated with gene IL10, and rs3024496 (risk allele G) associated with gene IL10.

### Claim 14 (depends on 1)

The method of claim 1, wherein the multi-omic model comprises a second subarchitecture for processing microbiome-associated input data, said second subarchitecture structured to return microbial taxonomic abundances of the microbiome state, said second subarchitecture further structured to return microbial diversity indices of a whole microbial community or a subset of the whole microbial community, and functional data, and said second subarchitecture further structured to transform microbial taxonomic and functional abundances to compositionally transformed and arithmetically derived values.

### Claim 15 (depends on 1)

The method of claim 1, further comprising: returning a set of genomic features and a set of microbiome features for the subject from the multi-omic model, and generating the personalized intervention plan from the set of genomic features and the set of microbiome features.

### Claim 16 (depends on 15)

The method of claim 15, wherein the set of microbiome features comprises features associated with: Akkermansia, Alistipes, Anaerostipes, Candidatus Soleaferrea, Desulfovibrio, Escherichia-Shigella, Eubacterium coprostanoligenes group, Eubacterium hallii group, Eubacterium ventriosum group, Fusicatenibacter, Haemophilus, Holdemanella, Intestinimonas, Lachnospira, Lactobacillus, Megasphaera, Moryella, Parabacteroides, Phascolarctobacterium, Prevotella, Ruminococcus torques group, Streptococcus, Terrisporobacter, Tyzzerella, Unclassified genus CAG-352 of Ruminococcaceae family, Unclassified genus CAG-56 of Lachnospiraceae family, Unclassified genus Clostridia UCG-014, Unclassified genus GCA-900066575 of Lachnospiraceae family, Unclassified genus of Anaerovoracaceae Family XIII AD3011 group, Unclassified genus UCG-009 of Butyricicoccaceae family, and Unclassified genus UCG-010 of Oscillospirales order, in relation to FGID symptoms of the subject.

### Claim 17 (depends on 15)

The method of claim 15, wherein the set of microbiome features comprises features associated with Parabacteroides, Unclassified genus of Anaerovoracaceae Family XIII AD3011 group, Lachnospira, Terrisporobacter, Eubacterium coprostanoligenes group, Intestinimonas, Prevotella, Lactobacillus, Phascolarctobacterium, and Unclassified genus UCG-009 of Butyricicoccaceae family in relation to constipation and diarrhea symptoms of the subject.

### Claim 18 (depends on 15)

The method of claim 15, wherein the set of microbiome features comprises features associated with Unclassified genus Clostridia UCG-014, Escherichia-Shigella, Megasphaera, Tyzzerella, Moryella, and Fusicantenibacter in relation to IBS symptoms of the subject.

### Claim 19 (depends on 15)

The method of claim 15, wherein generating the personalized intervention plan comprises returning a dietary recommendation configured to adjust taxonomic abundances and microbiome function represented by microorganism taxa of the set of microbiome features, based upon risk alleles of the set of genomic features and microbiome features of the subject.

### Claim 20 (depends on 15)

The method of claim 15, wherein the personalized intervention plan is delivered digitally through a mobile device application, and further comprises an application-interface between a coaching entity and the subject.

### Claim 21 (depends on 1)

The method of claim 1, wherein the multi-omic model comprises architecture for processing demographic data of the subject, biometric data of the subject, genomic data derived from the set of samples, and microbiome data derived from the set of samples.

### Claim 22 (depends on 1)

The method of claim 1, wherein at least one of generating the genomic profile, the baseline and follow up microbiome states, the set of signatures, and the personalized intervention plan comprises refining the multi-omic model upon:
collecting a set of training data streams derived from a population of subjects, the set of training data streams capturing genetic data, microbiome data, biometric data, and lifestyle data, paired with diagnostic and therapeutic information, from the population of subjects,
applying a set of transformation operations to the set of training data streams, creating a training dataset derived from the set of training data streams and the set of transformation operations, and training the multi-omic model in one or more stages, based upon the training dataset.
